[an error occurred while processing this directive] ����Ƥ���Բ�ѧ��־ 2011, 37(1) 23-25 DOI:     ISSN: 2096-5540 CN: 32-1880/R

����Ŀ¼ | ����Ŀ¼ | ������� | �߼�����                                                            [��ӡ��ҳ]   [�ر�]
����
��չ����
������Ϣ
Supporting info
PDFȫ��
[HTMLȫ��]
�����
�����뷴��
�ѱ����Ƽ�������
�����ҵ����
�������ù�����
����
Email Alert
���·���
���������Ϣ
���Ĺؼ����������
�̺۰�
���������������
��ٻ�
֣��
PubMed
Article by Xu,Q.N
Article by Zheng,c

Ĥ������A2�ṹ���ܼ��������Ƥ������ϵ���о���չ

��ٻ�,֣��

�Ϻ���ͨ��ѧҽѧԺ�������ҽԺƤ����

ժҪ��

Ĥ������A2��һ�ָ������ԡ������֬��Ĥ��ص��ס����Ե��塢������塢���ľ������ʽ������Ƥ��������ϸ���У���ͨ���ٽ������γ�ϸ��DNA�ϳɡ���TLR4Ϊ;�������ϸ���໥���á���β2GPI��ͬӰ������øϵͳ������ѧ���ܣ��ڶ������Ƥ����������м��������֬�ۺ����Լ��۸�����۰��з������á�

�ؼ����� �̺۰�  

Annexin A2: structure, function and relevance to associated skin diseases

Abstract:

As a calcium-dependent, phospholipid membrane-binding protein, annexin A2 exists as a monomer, heterodimer or tetramer in skin tissue and many cells. Annexin A2 plays a critical role in various skin diseases, including psoriasis, antiphospholipid syndrome, keloids and scar cancer by promoting DNA synthesis in keratinocytes, interacting with macrophages through Toll-like receptor 4, and affecting plasmin system together with β2-glycoprotein I (β2GPI��.

Keywords: scar��cancer  
�ո����� 2010-08-06 �޻����� 2010-09-13 ����淢������ 2011-01-10 
DOI:
������Ŀ:

ͨѶ����: ��ٻ�
���߼��:

�ο����ף�

[1] Spano F, Raugei G, Palla E, Colella C, Melli M.Characterization of the human lipocortin-2-encoding multigene family: its structure suggests the existence of a short amino acid unit undergoing duplication.Gene. 1990 Nov 15;95(2):243-51. [2] Muimo R.Regulation of CFTR function by annexin A2-S100A10 complex in health and disease.Gen Physiol Biophys. 2009;28 Spec No Focus:F14-9. [3] Hayes MJ, Shao DM, Grieve A, Levine T, Bailly M, Moss SE.Annexin A2 at the interface between F-actin and membranes enriched in phosphatidylinositol 4,5,-bisphosphate.Biochim Biophys Acta. 2009 Jun;1793(6):1086-95. Epub 2008 Oct 29. [4] Dreier R, Schmid KW, Gerke V, Riehemann K.Differential expression of annexins I, II and IV in human tissues: an immunohistochemical study.Histochem Cell Biol. 1998 Aug;110(2):137-48. [5] Waisman DM. Annexin II tetramer: structure and function. Mol Cell Biochem. 1995 Aug-Sep;149-150:301-22. Review. [6] Nestle, F. et al. Mechanisms of Disease: Psoriasis. New England Journal of Medicine July 2009;361;5:496-508. [7] Yamane Y, Moriyama K, Yasuda C, Miyata S, Aihara M, Ikezawa Z, Miyazaki K.New horny layer marker proteins for evaluating skin condition in atopic dermatitis.Int Arch Allergy Immunol. 2009;150(1):89-101. Epub 2009 Apr 2. [8] Zhao S, Huang L, Wu J, Zhang Y, Pan D, Liu X.Vascular endothelial growth factor upregulates expression of annexin A2 in vitro and in a mouse model of ischemic retinopathy.Mol Vis. 2009 Jun 17;15:1231-42. [9] Chiang Y, Schneiderman MH, Vishwanatha JK.Annexin II expression is regulated during mammalian cell cycle. Cancer Res. 1993 Dec 15;53(24):6017-21. [10] Xu TR, Rumsby MG.Phorbol ester-induced translocation of PKC epsilon to the nucleus in fibroblasts: identification of nuclear PKC epsilon-associating proteins.FEBS Lett. 2004 Jul 16;570(1-3):20-4. [11] Swisher JF, Burton N, Bacot SM, Vogel SN, Feldman GM. Annexin A2 tetramer activates human and murine macrophages through TLR4.Blood. 2010 Jan 21;115(3):549-58. Epub 2009 Nov 12. [12] Swisher JF, Khatri U, Feldman GM. Annexin A2 is a soluble mediator of macrophage activation.J Leukoc Biol. 2007 Nov;82(5):1174-84. Epub 2007 Aug 22. [13] Mayer G, Poirier S, Seidah NG.Annexin A2 is a C-terminal PCSK9-binding protein that regulates endogenous low density lipoprotein receptor levels.J Biol Chem. 2008 Nov 14;283(46):31791-801. Epub 2008 Sep 17. [14] Alexandroff AB, Pauriah M, Lang CC, Struthers AD, Armstrong DJ.Atherosclerosis as a systemic feature of psoriasis.Clin Exp Dermatol. 2010 Jul 23. [Epub ahead of print] [15] Li X, Syrovets T, Genze F, Pitterle K, Oberhuber A, Orend KH, Simmet T.Plasmin triggers chemotaxis of monocyte-derived dendritic cells through an Akt2-dependent pathway and promotes a T-helper type-1 response.Arterioscler Thromb Vasc Biol. 2010 Mar;30(3):582-90. Epub 2010 Jan 7. [16] Zhao S, Huang L, Wu J, Zhang Y, Pan D, Liu X.Vascular endothelial growth factor upregulates expression of annexin A2 in vitro and in a mouse model of ischemic retinopathy.Mol Vis. 2009 Jun 17;15:1231-42. [17] Espinosa G, Cervera R.Antiphospholipid syndrome: frequency, main causes and risk factors of mortality.Nat Rev Rheumatol. 2010 May;6(5):296-300. Epub 2010 Apr 13. Review. [18] Vanhoutte PM.Endothelial dysfunction: the first step toward coronary arteriosclerosis.Circ J. 2009 Apr;73(4):595-601. Epub 2009 Feb 18. Review. [19] Zhang J, McCrae KR.Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein I antibodies.Blood. 2005 Mar 1;105(5):1964-9. [20] Romay-Penabad Z, Montiel-Manzano MG, Shilagard T, Papalardo E, Vargas G, Deora AB, Wang M, Jacovina AT, Garcia-Latorre E, Reyes-Maldonado E, Hajjar KA, Pierangeli SS.Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo.Blood. 2009 Oct 1;114(14):3074-83. Epub 2009 Jul 23. [21] Cockrell E, Espinola RG, McCrae KR.Annexin A2: biology and relevance to the antiphospholipid syndrome.Lupus. 2008 Oct;17(10):943-51. Review. [22] Cesarman GM, Guevara CA, Hajjar KA.An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). Annexin II mediated enhancement of t-PA-dependent plasminogen activation.J Biol Chem. 1994 Aug 19;269(33):21198-203. [23] Zhu H, Fan X, Yu Z, Liu J, Murata Y, Lu J, Zhao S, Hajjar KA, Lo EH, Wang X.Annexin A2 combined with low-dose tPA improves thrombolytic therapy in a rat model of focal embolic stroke.J Cereb Blood Flow Metab. 2010 Jan 13. [24] Gugliucci A, Ghitescu L.Is diabetic hypercoagulability an acquired annexinopathy? Glycation of annexin II as a putative mechanism for impaired fibrinolysis in diabetic patients.Med Hypotheses. 2002 Sep;59(3):247-51. [25] Krone KA, Allen KL, McCrae KR.Impaired fibrinolysis in the antiphospholipid syndrome.Curr Rheumatol Rep. 2010 Feb;12(1):53-7. [26] Cesarman-Maus G, Ríos-Luna NP, Deora AB, Huang B, VilYamane Y, Moriyama K, Yasuda C, Miyata S, Aihara M, Ikezawa Z, Miyazaki K.New horny layer marker proteins for evaluating skin condition in atopic dermatitis.Int Arch Allergy Immunol. 2009;150(1):89-101. Epub 2009 Apr 2. [27] Ao W, Zheng H, Chen XW, Shen Y, Yang CD.Anti-annexin II antibody is associated with thrombosis and/or pregnancy morbidity in antiphospholipid syndrome and systemic lupus erythematosus with thrombosis.Rheumatol Int. 2010 Mar 13. [28] Satish L, Lyons-Weiler J, Hebda PA, Wells A.Gene expression patterns in isolated keloid fibroblasts.Wound Repair Regen. 2006 Jul-Aug;14(4):463-70. [29] Huang Y, Jin Y, Yan CH, Yu Y, Bai J, Chen F, Zhao YZ, Fu SB.Involvement of Annexin A2 in p53 induced apoptosis in lung cancer.Mol Cell Biochem. 2008 Feb;309(1-2):117-23. Epub 2007 Nov 16. [30] Siever DA, Erickson HP. Extracellular annexin II Int J Biochem Cell Biol. 1997 Nov;29(11):1219–1223. [31] Murphy-Ullrich JE.The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state?J Clin Invest. 2001 Apr;107(7):785-90.

�������������

�������� (��ע��:��վʵ�������Ը�, �벻Ҫ������ѧ���޹ص�����!�������ݲ�����վ�۵�.)

Copyright 2008 by ����Ƥ���Բ�ѧ��־